Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial.

Source:http://linkedlifedata.com/resource/pubmed/id/9137522

Download in:

View as

General Info

PMID
9137522